Profund Advisors LLC lifted its position in Mylan N.V. (NASDAQ:MYL) by 0.7% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 55,964 shares of the company’s stock after acquiring an additional 393 shares during the period. Profund Advisors LLC’s holdings in Mylan N.V. were worth $2,173,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in the company. Loews Corp purchased a new position in Mylan N.V. during the second quarter valued at approximately $223,000. BlueMountain Capital Management LLC grew its position in Mylan N.V. by 43.3% during the second quarter. BlueMountain Capital Management LLC now owns 243,618 shares of the company’s stock valued at $9,457,000 after purchasing an additional 73,638 shares in the last quarter. Amalgamated Bank grew its position in Mylan N.V. by 79.7% during the second quarter. Amalgamated Bank now owns 59,273 shares of the company’s stock valued at $2,301,000 after purchasing an additional 26,290 shares in the last quarter. Edmond DE Rothschild Holding S.A. grew its position in Mylan N.V. by 28.8% during the second quarter. Edmond DE Rothschild Holding S.A. now owns 11,438 shares of the company’s stock valued at $445,000 after purchasing an additional 2,559 shares in the last quarter. Finally, BlackRock Inc. grew its position in Mylan N.V. by 4.5% during the second quarter. BlackRock Inc. now owns 40,574,158 shares of the company’s stock valued at $1,575,089,000 after purchasing an additional 1,751,515 shares in the last quarter. 71.97% of the stock is currently owned by institutional investors and hedge funds.

A number of research analysts recently commented on MYL shares. Cowen and Company reaffirmed a “market perform” rating and set a $43.00 price objective (down from $55.00) on shares of Mylan N.V. in a research report on Sunday, May 21st. Barclays PLC raised shares of Mylan N.V. from an “equal weight” rating to an “overweight” rating and boosted their price objective for the company from $47.00 to $50.00 in a research report on Monday, May 22nd. Zacks Investment Research raised shares of Mylan N.V. from a “sell” rating to a “hold” rating in a research report on Thursday, May 25th. Wells Fargo & Company reaffirmed a “market perform” rating and set a $40.00 price objective on shares of Mylan N.V. in a research report on Wednesday, May 31st. Finally, Royal Bank Of Canada reaffirmed a “hold” rating and set a $41.00 price objective on shares of Mylan N.V. in a research report on Tuesday, June 13th. Two investment analysts have rated the stock with a sell rating, ten have assigned a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $43.43.

Shares of Mylan N.V. (MYL) opened at 31.96 on Monday. The stock has a 50 day moving average of $32.33 and a 200-day moving average of $37.58. Mylan N.V. has a 52 week low of $29.39 and a 52 week high of $45.87. The firm has a market capitalization of $17.14 billion, a PE ratio of 25.84 and a beta of 1.31.

Mylan N.V. (NASDAQ:MYL) last released its earnings results on Wednesday, August 9th. The company reported $1.10 earnings per share for the quarter, missing the consensus estimate of $1.18 by ($0.08). Mylan N.V. had a net margin of 5.51% and a return on equity of 22.42%. The firm had revenue of $2.96 billion during the quarter, compared to the consensus estimate of $3 billion. During the same period in the prior year, the business posted $1.16 earnings per share. Mylan N.V.’s quarterly revenue was up 15.7% compared to the same quarter last year. Equities analysts anticipate that Mylan N.V. will post $4.52 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Profund Advisors LLC Has $2.17 Million Stake in Mylan N.V. (MYL)” was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this story on another publication, it was copied illegally and reposted in violation of international trademark & copyright law. The legal version of this story can be accessed at https://www.thecerbatgem.com/2017/09/18/profund-advisors-llc-has-2-17-million-stake-in-mylan-n-v-myl.html.

Mylan N.V. Company Profile

Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.

Institutional Ownership by Quarter for Mylan N.V. (NASDAQ:MYL)

Receive News & Stock Ratings for Mylan N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan N.V. and related stocks with our FREE daily email newsletter.